Search keywords: glucagon
Images found: 2
Images per page:
Images from Adobe Stock
GLP letter logo abstract creative design. GLP unique design, GLP minimalist element design.
GLP LOGO DESIGN
GLP three Letter Rounded rectangle boxes shape element symbol digital initial technology Media business logo design, Vector Template
GPP - Good Pharmacy Practices acronym, concept background
The letter GCG is hexagon shape
Endocrine Icon
GLP letter logo design on black background. GLP creative initials letter logo concept. GLP letter design.
Garvagliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
GCG shield logo.eps
GLP letter logo vector design, GLP simple and modern logo. GLP luxurious alphabet design
GLP circle letter logo design with circle and ellipse shape. GLP ellipse letters with typographic style. The three initials form a circle logo. GLP Circle Emblem Abstract Monogram Letter Mark Vector.
Antidiabetic drugs. Diabetes mellitus type 1, pancreas's failure to produce enough insulin and type 2, cells fail to respond to insulin (Insulin resistance). Result in high blood glucose levels.
Saxagliptin diabetes drug molecule. Inhibitor of dipeptidyl peptidase-4 (DPP4). Skeletal formula.
GPP - Good Pharmacy Practices acronym. business concept background. vector illustration concept with keywords and icons. lettering illustration with icons for web banner, flyer
Grunge black non compliance word rubber seal stamp on white background
GLP initial letter real estate builders logo design vector. construction ,housing, home marker, property, building, apartment, flat, compartment, business, corporate, house rent, rental, commercial
GCG letter cube logo
Business logo letter line cube. icon design template. geometric isolated monogram letter GCG
Diabetes mellitus type 1, pancreas's failure to produce enough insulin. High blood glucose levels. Diagram illustration.
Diabetes mellitus type 2, cells fail to respond to insulin (Insulin resistance). high blood glucose levels. Vector Diagram illustration.
Miglitol molecular structure, flat skeletal chemical formula. Alpha-glucosidase inhibitor drug used to treat Diabetes type 2. Vector illustration.
Omarigliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Rosglitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Nateglinide molecular structure, flat skeletal chemical formula. Meglitinide drug used to treat Diabetes type 2. Vector illustration.
Acarbose molecular structure, flat skeletal chemical formula. Alpha-glucosidase inhibitor drug used to treat Diabetes type 2. Vector illustration.
Lobeglitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Linagliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
 Insulin mechanism of action, regulates glucose metabolism and glucose blood level. Insulin is the key that unlocks glucose channel. Insulin resistance. Vector illustration.
Repaglinide molecular structure, flat skeletal chemical formula. Meglitinide drug used to treat Diabetes type 2. Vector illustration.
Insulin mechanism of action, regulates glucose metabolism and glucose blood level. Insulin is the key that unlocks glucose channel. Insulin resistance. Vector illustration.
Evogliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Canagliflozin molecular structure, flat skeletal chemical formula. SGLT2 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Carbutamide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Metformin molecular structure, flat skeletal chemical formula. Biguanide drug used to treat Diabetes type 2. Vector illustration.
Gliclazide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Sorbinil molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Zenarestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Diabetes mellitus type 2, cells fail to respond to insulin (Insulin resistance). high blood glucose levels. Vector Diagram illustration.
Phospholipase C (PLC). Diacylglycerol (DAG) and Inositol 1,4,5 trisphosphate. Protein kinase C (PKC). Vector illustration.
Phospholipase C (PLC). Diacylglycerol (DAG) and Inositol 1,4,5 trisphosphate. Protein kinase C (PKC). Vector illustration.
Gemigliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Darglitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Rivoglitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Tolbutamide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Ranirestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Insulin, regulates glucose metabolism and glucose blood level. Insulin is the key that unlocks glucose channel. Type 1 diabetes Vector illustration.
Tolazamide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Fidarestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Alrestatin molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Diabetes mellitus type 1, pancreas's failure to produce enough insulin and type 2, cells fail to respond to insulin (Insulin resistance). Result in high blood glucose levels. Vector illustration
Insulin mechanism of action, regulates glucose metabolism and glucose blood level. Insulin is the key that unlocks glucose channel. Insulin resistance. Vector illustration.
Acetohexamide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Ponalrestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Diabetes mellitus type 1, pancreas's failure to produce enough insulin and type 2, cells fail to respond to insulin (Insulin resistance). Result in high blood glucose levels. Vector illustration.
Netoglitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Glipizide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Englitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Tenegliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Futuristic hud banner that have word non compliance on user interface screen on blue background
Aleglitazar molecular structure, flat skeletal chemical formula. Dual PPAR agonist drug used to treat Diabetes type 2. Vector illustration.
Mitiglinide molecular structure, flat skeletal chemical formula. Meglitinide drug used to treat Diabetes type 2. Vector illustration.
Diabetes mellitus type 1, pancreas's failure to produce enough insulin and type 2, cells fail to respond to insulin (Insulin resistance). Result in high blood glucose levels. Vector illustration.
Zopolrestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Tolrestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Diabetes mellitus type 2, cells fail to respond to insulin (Insulin resistance). high blood glucose levels. Vector Diagram illustration
Trelagliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Red color inserted label with word non compliance on gray background
Torglitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Diabetes mellitus type 1, pancreas's failure to produce enough insulin and type 2, cells fail to respond to insulin (Insulin resistance). Result in high blood glucose levels. Vector illustration
Remogliflozin molecular structure, flat skeletal chemical formula. SGLT2 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Muraglitazar molecular structure, flat skeletal chemical formula. Dual PPAR agonist drug used to treat Diabetes type 2. Vector illustration.
Table of cAMP mediated cell response - GPCR Gs signalling. Hormone mediated liver, adipose, muscle, bone and kidney response.
Tesaglitazar molecular structure, flat skeletal chemical formula. Dual PPAR agonist drug used to treat Diabetes type 2. Vector illustration.
Sitagliptin molecular structure, flat skeletal chemical formula. DPP4 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Envelope and letter sign with word compliance as the headline
Chlorpropamide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Tofogliflozin molecular structure, flat skeletal chemical formula. SGLT2 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Sotagliflozin molecular structure, flat skeletal chemical formula. SGLT2 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Grunge green calibrated word square rubber seal stamp on white background
Luseogliflozin molecular structure, flat skeletal chemical formula. SGLT2 inhibitor drug used to treat Diabetes type 2. Vector illustration.
 Diabetes mellitus type 1, pancreas's failure to produce enough insulin and type 2, cells fail to respond to insulin (Insulin resistance). Result in high blood glucose levels. Vector illustration
Pioglitazone molecular structure, flat skeletal chemical formula. Thiazolidinedione drug used to treat Diabetes type 2. Vector illustration.
Ipragliflozin molecular structure, flat skeletal chemical formula. SGLT2 inhibitor drug used to treat Diabetes type 2. Vector illustration.
Salfredin B11 molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Metahexamide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Glycyclamide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Minalrestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Epalrestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Color megaphone icon with word non compliance in white banner on blue background
Pancreas Icon
Glibornuride molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Glycopyramide molecular structure, flat skeletal chemical formula. Sulfonylureas  drug used to treat Diabetes type 2. Vector illustration.
Insulin mechanism of action, regulates glucose metabolism and glucose blood level. Insulin is the key that unlocks glucose channel. Insulin resistance. Vector illustration.
Blue color of futuristic hud banner that have word calibration  on user interface screen on black background
Ripped gray paper background that have word calibration under torn part
Lidorestat molecular structure, flat skeletal chemical formula. Aldose reductase inhibitors drug used to treat Diabetes type 2. Vector illustration.
Futuristic hud banner that have word under validation on user interface screen on blue background
Grunge red compliance word rubber seal stamp on white background
Ertugliflozin molecular structure, flat skeletal chemical formula. SGLT2 inhibitor drug used to treat Diabetes type 2. Vector illustration.
PI3K, Akt Pathway. phosphatidylinositol 3 kinase (PI3K). AKT, protein kinase B. PIP2 and PIP3. Vector illustration.
Next page
/ 10